SciELO Data

Metrics

12,957 Downloads

Featured Dataverses

In order to use this feature you must have at least one published or linked dataverse.

Publish Dataverse

Are you sure you want to publish your dataverse? Once you do so it must remain published.

Publish Dataverse

This dataverse cannot be published because the dataverse it is in has not been published.

Delete Dataverse

Are you sure you want to delete your dataverse? You cannot undelete this dataverse.

File Type: Tabular Data

331 to 340 of 544 Results

stf_dados_sessoes_pv_16-21_001.tab Apr 19, 2023 - Dados das sessões virtuais de julgamento do Supremo Tribunal Federal (agosto de 2016 a junho de 2021) Tabular Data - 12.8 KB - 15 Variables, 243 Observations - UNF:6:LN0ZaWPGAPii/mR5bTXREQ==
JAOS-2022-0461_Database-1.tab Apr 17, 2023 - Data for: Immunoexpression profile of hypoxia-inducible factor (HIF) targets in potentially malignant and malignant oral lesions: A pilot study Tabular Data - 5.8 KB - 38 Variables, 55 Observations - UNF:6:J3ulTQ0LVf8iFeGygVfJ+w==
JAOS-2022-0461_Database.tab Apr 17, 2023 - Data for: Immunoexpression profile of hypoxia-inducible factor (HIF) targets in potentially malignant and malignant oral lesions: A pilot study Tabular Data - 5.4 KB - 38 Variables, 55 Observations - UNF:6:HOIh/zOBeantQsso+R4syw==
Supplementary_Table_01.tab Apr 17, 2023 - Data for: Immunoexpression profile of hypoxia-inducible factor (HIF) targets in potentially malignant and malignant oral lesions: A pilot study Tabular Data - 1.3 KB - 5 Variables, 15 Observations - UNF:6:w6jBr5irgGhh7x32sTYtqA== Table_S1 - Details of the immunohistochemical procedure.
Supplementary_Table_02.tab Apr 17, 2023 - Data for: Immunoexpression profile of hypoxia-inducible factor (HIF) targets in potentially malignant and malignant oral lesions: A pilot study Tabular Data - 1.1 KB - 6 Variables, 28 Observations - UNF:6:VZ1p1O2jrTE/ZXMO97ivlg== Table_S2 - Association between the clinicopathological data and the 3-year disease-free survival of oral squamous cell carcinoma patients (n=21).
Supplementary_Table_03.tab Apr 17, 2023 - Data for: Immunoexpression profile of hypoxia-inducible factor (HIF) targets in potentially malignant and malignant oral lesions: A pilot study Tabular Data - 1.2 KB - 6 Variables, 31 Observations - UNF:6:LJo2PNfGULbvi3OZtKOKkA== Table_S3 - Association between the clinicopathological data and the 3-year overall survival of oral squamous cell carcinoma patients (n=21).
Supplementary_Table_04.tab Apr 17, 2023 - Data for: Immunoexpression profile of hypoxia-inducible factor (HIF) targets in potentially malignant and malignant oral lesions: A pilot study Tabular Data - 3.6 KB - 28 Variables, 22 Observations - UNF:6:Qg+q+dk7OJrTLOD1n0pWsg== Table_S4 - Association between the immunoexpression of metabolism-related biomarkers and the clinicopathological data of patients with oral potentially malignant disorders.
Supplementary_Table_05.tab Apr 17, 2023 - Data for: Immunoexpression profile of hypoxia-inducible factor (HIF) targets in potentially malignant and malignant oral lesions: A pilot study Tabular Data - 4.1 KB - 28 Variables, 26 Observations - UNF:6:pKdiOauI7PLSXgZJPEeM1w== Table_S5 - Association between the immunoexpression of metabolism-related biomarkers and the clinicopathological data of oral squamous cell carcinoma patients.
Supplementary_Table_06.tab Apr 17, 2023 - Data for: Immunoexpression profile of hypoxia-inducible factor (HIF) targets in potentially malignant and malignant oral lesions: A pilot study Tabular Data - 1.6 KB - 13 Variables, 35 Observations - UNF:6:mb5ffkhR8ufWA+u+6OMdiA== Table_S6 - Association between the immunoexpression frequencies of the metabolism-related biomarkers and the 3-year disease-free survival of oral squamous cell carcinoma patients.
Supplementary_Table_07.tab Apr 17, 2023 - Data for: Immunoexpression profile of hypoxia-inducible factor (HIF) targets in potentially malignant and malignant oral lesions: A pilot study Tabular Data - 1.3 KB - 6 Variables, 34 Observations - UNF:6:piCeOO75bSmU64JGFpSMxQ== Table_S7 - Association between the immunoexpression frequencies of the metabolism-related biomarkers and the 3-year overall survival of oral squamous cell carcinoma patients.

stf_dados_sessoes_pv_16-21_001.tab

Apr 19, 2023 - Dados das sessões virtuais de julgamento do Supremo Tribunal Federal (agosto de 2016 a junho de 2021)

Tabular Data - 12.8 KB - 15 Variables, 243 Observations -

JAOS-2022-0461_Database-1.tab

Apr 17, 2023 - Data for: Immunoexpression profile of hypoxia-inducible factor (HIF) targets in potentially malignant and malignant oral lesions: A pilot study

Tabular Data - 5.8 KB - 38 Variables, 55 Observations -

JAOS-2022-0461_Database.tab

Apr 17, 2023 - Data for: Immunoexpression profile of hypoxia-inducible factor (HIF) targets in potentially malignant and malignant oral lesions: A pilot study

Tabular Data - 5.4 KB - 38 Variables, 55 Observations -

Supplementary_Table_01.tab

Apr 17, 2023 - Data for: Immunoexpression profile of hypoxia-inducible factor (HIF) targets in potentially malignant and malignant oral lesions: A pilot study

Tabular Data - 1.3 KB - 5 Variables, 15 Observations -

Table_S1 - Details of the immunohistochemical procedure.

Supplementary_Table_02.tab

Apr 17, 2023 - Data for: Immunoexpression profile of hypoxia-inducible factor (HIF) targets in potentially malignant and malignant oral lesions: A pilot study

Tabular Data - 1.1 KB - 6 Variables, 28 Observations -

Table_S2 - Association between the clinicopathological data and the 3-year disease-free survival of oral squamous cell carcinoma patients (n=21).

Supplementary_Table_03.tab

Apr 17, 2023 - Data for: Immunoexpression profile of hypoxia-inducible factor (HIF) targets in potentially malignant and malignant oral lesions: A pilot study

Tabular Data - 1.2 KB - 6 Variables, 31 Observations -

Table_S3 - Association between the clinicopathological data and the 3-year overall survival of oral squamous cell carcinoma patients (n=21).

Supplementary_Table_04.tab

Apr 17, 2023 - Data for: Immunoexpression profile of hypoxia-inducible factor (HIF) targets in potentially malignant and malignant oral lesions: A pilot study

Tabular Data - 3.6 KB - 28 Variables, 22 Observations -

Table_S4 - Association between the immunoexpression of metabolism-related biomarkers and the clinicopathological data of patients with oral potentially malignant disorders.

Supplementary_Table_05.tab

Apr 17, 2023 - Data for: Immunoexpression profile of hypoxia-inducible factor (HIF) targets in potentially malignant and malignant oral lesions: A pilot study

Tabular Data - 4.1 KB - 28 Variables, 26 Observations -

Table_S5 - Association between the immunoexpression of metabolism-related biomarkers and the clinicopathological data of oral squamous cell carcinoma patients.

Supplementary_Table_06.tab

Apr 17, 2023 - Data for: Immunoexpression profile of hypoxia-inducible factor (HIF) targets in potentially malignant and malignant oral lesions: A pilot study

Tabular Data - 1.6 KB - 13 Variables, 35 Observations -

Table_S6 - Association between the immunoexpression frequencies of the metabolism-related biomarkers and the 3-year disease-free survival of oral squamous cell carcinoma patients.

Supplementary_Table_07.tab

Apr 17, 2023 - Data for: Immunoexpression profile of hypoxia-inducible factor (HIF) targets in potentially malignant and malignant oral lesions: A pilot study

Tabular Data - 1.3 KB - 6 Variables, 34 Observations -

Table_S7 - Association between the immunoexpression frequencies of the metabolism-related biomarkers and the 3-year overall survival of oral squamous cell carcinoma patients.

Add Data

Share Dataverse

Link Dataverse

Reset Modifications